Nuvalent
- Greg Smith
Greg Smith is currently the Associate Director of Regulatory Affairs and Global Regulatory CMC Lead at Nuvalent. Prior to Nuvalent, Greg worked as the Director of Regulatory Affairs and Global Regulatory CMC Lead at Nuvalent, Inc. for 1 year and 1 month. Greg also spent 4 years and 2 months as the Associate Director of Regulatory Affairs - CMC at Agios Pharmaceuticals and 6 years and 6 months as a Scientist III - Analytical Development at Alkermes. Greg began their career as an Associate Scientist at PerkinElmer, Inc. where they worked for 4 years and 1 month.
Greg Smith has a Master's Degree from Northeastern University in Chemistry and a Bachelor of Science (B.S.) from Vanderbilt University in Chemistry.
Org chart
Upgrade to view 0 reports
Teams
This person is not in any teams
Offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.
